Member of UN Global Compact
Headquarters in USA
Author: Willliam Baue, SocialFunds.com
A German rating agency reports that many pharmaceutical companies are failing to follow the example of the sector’s leaders in solving environmental and social problems...The report analyzed the 22 largest pharmaceutical companies in the world, based...
...The Gates Foundation, partnerships with Merck, Bristol-Myers Squibb and the Harvard AIDS Institute all form "very strong" U.S. components of the southern African nation's Aids fight.
Author: Walden Asset Management
[includes shareholder resolutions on the following issues & companies: Climate Change - Exxon Mobil, ChevronTexaco and Occidental Petroleum; Mercury Pollution - J.C. Penney and HCA; Indigenous Peoples' Rights - Lehman Brothers; Sweatshop/Vendor...
Author: Ed Silverman, Star-Ledger [New Jersey]
Rather than suffer a bruising battle for its Cipro patent and risk more damage to its image, the German drug giant will sell the anthrax-fighting antibiotic to the [U.S.] federal government at a drastically reduced price -- 95 cents a tablet, about...
Fighting Back in Botswana: Nearly 36 percent of adults in Botswana are believed to have HIV, the virus that causes AIDS.
Author: NewsHour with Jim Lehrer, PBS
Elizabeth Farnsworth reports on how Botswana's government is trying to tackle the crisis, in part three of a four-part series. "Diamonds from mines like this are crucial to Botswana's economy, and as more and more workers ended up sick, Debswana ...
- Related companies: Bristol-Myers Squibb Debswana (joint venture De Beers & Botswana Govt.)
Cheaper drugs for Africa: Manufacturer [Bristol-Myers Squibb] to relax its patent on two Aids remedies
Author: Andrew Clark and Julian Borger, Guardian [UK]
- Related companies: Bristol-Myers Squibb
Merck, Bristol-Myers Squibb Announce Major Price Reductions for Poorest Countries: Major Access Progress but Questions Remain
Author: John S. James, AIDS Treatment News
...Merck...announced it would sell Crixivan...in some poor countries for $600 per patient per year...Merck claims that it will not make a profit...Bristol-Myers Squibb Company announced that it was making its drugs ddI and d4T available "in every...
Author: Prince of Wales International Business Leaders Forum in collaboration with UNAIDS and Global Business Council on HIV/AIDS
[Section 5, "Profiles of business activities in response to HIV/AIDS", includes profiles of American International Assurance, Thailand; The Body Shop, Japan; Warsaw Marriott Hotel; Larsen & Toubro, India; Volkswagen do Brasil; Molson Breweries,...
Author: Instituto Ethos
[refers to Abbott Laboratories, Accenture, Accor, Aché Laboratórios Farmacêuticos, Alcatel, Amanco, Anglo American, AngloGold, Avon, Banco Bradesco, Banco do Brasil, Bandeirante Energia, BankBoston, BASF, Bayer, Boehringer Ingelheim, Bristol-Myers...
- Related stories: Instituto Ethos report: "Business Commitment to the Millennium Development Goals"
- Related companies: Abbott Laboratories Accenture Accor Aché Laboratórios Farmacêuticos Alcatel (now Alcatel-Lucent) Alcoa Amanco (part of Mexichem) Anglo American AngloGold Ashanti Avon Banco Bradesco Banco do Brasil Bandeirante Energia BASF Bayer Boehringer Ingelheim Bristol-Myers Squibb British American Tobacco Bunge Cadbury Schweppes (now Cadbury) Companhia Siderúrgica de Tubarão (CST) Companhia Vale do Rio Doce (now Vale) Eastman Kodak Esso (part of ExxonMobil) ExxonMobil Ford GlaxoSmithKline Grupo Pão de Açúcar - Companhia Brasileira de Distribuição HP (Hewlett-Packard) IBM Merck Merck Sharp & Dohme (part of Merck) Microsoft Natura Nestlé Odebrecht PepsiCo Petrobras Pfizer Praxair Roche Royal Philips Electronics Sadia Schering-Plough Seara Alimentos Shell Siemens Souza Cruz (part of British American Tobacco) Telecom Italia Telefónica Tim Maxitel (part of Telecom Italia) Unilever White Martins Gases Industriais (part of Praxair)